Current concepts of abnormal motor disorder: an experimental model of attentional deficit disorder.
D000661:Amphetamine / Q000008:administration & dosage; D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects; D001289:Attention Deficit Disorder with Hyperactivity / Q000503:physiopathology; D001362:Avoidance Learning / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D002800:Cholinesterase Inhibitors / Q000009:adverse effects; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology; D006801:Humans; D006816:Huntington Disease / Q000503:physiopathology*; D006948:Hyperkinesis / Q000209:etiology; D008959:Models, Neurological; D009069:Movement Disorders / Q000503:physiopathology*; D009422:Nervous System Diseases / Q000503:physiopathology*; D018377:Neurotransmitter Agents / Q000502:physiology; D010300:Parkinson Disease / Q000503:physiopathology; D010830:Physostigmine / Q000008:administration & dosage; D051381:Rats; D005680:gamma-Aminobutyric Acid / Q000502:physiology
D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors; D018377:Neurotransmitter Agents; D005680:gamma-Aminobutyric Acid; D010830:Physostigmine; D000661:Amphetamine